Mixed Infections Pose Serious Financial Threat to Swine Industry
SWITZERLAND - New survey data released today shows that swine specialists worldwide believe mixed enteric and respiratory infections pose a serious problem to infected herds. They continue to represent a significant cost to the swine industry, despite...

Breakthrough discovery signals new hope in the battle against livestock parasites
BELGIUM - At last week's World Association for the Advancement of Veterinary Parasitology (WAAVP) Congress, Novartis Animal Health presented promising data on what is potentially the first new livestock anthelmintic class in 25 years, offering renewed...

Farm Animal Brands Key to Novartis Animal Health Growth
BASEL - Novartis Animal Health has been among the fastest growing companies in the animal health industry over the past three years, fueled not only by its strong stable of veterinary products for pets, but also by its continued emphasis and commitment...

Trial results cite most cost effective treatment for enteric and/or respiratory infections
BASEL - Novartis Animal Health has announced that results from seven recent field trials around the world showed that Denagard® / Tiamutin® provides the most cost-effective solution when compared head-to-head with tylosin and lincomycin – increasing margins...

Leading swine antibiotic Denagard acquired by Novartis
US - Denagard (tiamulin), a broad-spectrum swine antibiotic for control and treatment of certain swine bacterial diseases, has been purchased by Novartis Animal Health US, Inc.

Impact and control of ileitis, colitis on European swine is focus of international workshop
SWITZERLAND - The impact of ileitis and colitis on European swine production was the focus of a workshop help recently by Novartis Animal Health in Alpbach, Austria.